Correlation Between Syndax Pharmaceuticals and Adagene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Adagene, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Adagene.

Diversification Opportunities for Syndax Pharmaceuticals and Adagene

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Syndax and Adagene is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Adagene go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and Adagene

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to under-perform the Adagene. But the stock apears to be less risky and, when comparing its historical volatility, Syndax Pharmaceuticals is 1.39 times less risky than Adagene. The stock trades about -0.07 of its potential returns per unit of risk. The Adagene is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  233.00  in Adagene on September 17, 2024 and sell it today you would lose (27.00) from holding Adagene or give up 11.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Syndax Pharmaceuticals  vs.  Adagene

 Performance 
       Timeline  
Syndax Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Syndax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Adagene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Adagene is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Syndax Pharmaceuticals and Adagene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Syndax Pharmaceuticals and Adagene

The main advantage of trading using opposite Syndax Pharmaceuticals and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.
The idea behind Syndax Pharmaceuticals and Adagene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine